Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure

Our results point toward an ongoing consumption of CLU involved in the complex pathophysiology of HF and suggest CLU as novel and promising biomarker for prognosis in patients with chronic HF.